Volume 3, Issue 3, September 2019, Page: 52-54
Cardiorenal Syndrome in Acute Coronary Disease: A Current Perspective
Hedgar Berty Gutiérrez, Intensive Care Department, University Clinical-Surgical Hospital “Miguel Enríquez”, Havana, Cuba
Yenisey Arteaga Concepción, Intensive Care Department, University Clinical-Surgical Hospital “Miguel Enríquez”, Havana, Cuba
Cristians Auza-Santivañez, Intensive Care Department, University Clinical-Surgical Hospital “Miguel Enríquez”, Havana, Cuba
Received: Jun. 26, 2019;       Accepted: Aug. 4, 2019;       Published: Sep. 3, 2019
DOI: 10.11648/j.ccr.20190303.12      View  23      Downloads  17
Abstract
Acute coronary disease is one of the leading causes of death in the world. Currently 20-30% of these patients have acute renal failure forming part of the cardiorenal syndrome. Studies show that the evaluation of renal function through the estimated glomerular filtration rate (eGFR) is related to mortality in patients with cardiovascular disease, with greater precision in eGFR Chronic Kidney Disease Epidemiology Collaboration. Therefore, it is considered an immediate, easy and useful marker for the initial evaluation of patients with acute coronary disease.
Keywords
Acute Coronary Syndrome, Glomerular Filtration, Acute Renal Failure
To cite this article
Hedgar Berty Gutiérrez, Yenisey Arteaga Concepción, Cristians Auza-Santivañez, Cardiorenal Syndrome in Acute Coronary Disease: A Current Perspective, Cardiology and Cardiovascular Research. Vol. 3, No. 3, 2019, pp. 52-54. doi: 10.11648/j.ccr.20190303.12
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Parra Fuertes PJ, de la Fuente SI. Síndrome coronario agudo sin elevación persistente del segmento ST. En: Montejo CJ, de Lorenzo GA, Marco P, Ortiz C. Manual de medicina intensiva. 5ta edición. España: Elsevier; 2017. p. 105-109.
[2]
Gutiérrez HB, Benítez FDM (2018) Valor pronóstico de la función renal a corto plazo en pacientes con infarto agudo de miocardio. Revista Colombiana de Cardiología 25: 26-32.
[3]
Rodríguez-Jiménez AE, Negrín-Valdés T, Cruz-Inerarity H, Machural-de la Torre PJ. Síndrome cardiorrenal como predictor de mortalidad intrahospitalaria en el síndrome coronario agudo con elevación del segmento ST. Clínica e Investigación en Arteriosclerosis. 2018; 30 (4): 163-9.
[4]
Górriz Teruel JL, Beltrán Catalán S. Valoración de afección renal, disfunción renal aguda e hiperpotasemia por fármacos usados en cardiología y nefrotoxicidad por contrastes. Rev Esp Cardiol. 2011; 64: 1182-92.
[5]
Grodin JL. Hemodynamically, the kidney is at the heart of cardiorenal syndrome. CLEVELAND CLINIC 9500 EUCLID AVE, CLEVELAND, OH 44106 USA; 2018.
[6]
Di Lullo L, Bellasi A, Russo D, Cozzolino M, Ronco C. Cardio-renal acute kidney injury: Epidemiology, presentation, causes, pathophysiology and treatment. Int J Cardiol. 2017; 227: 143-50. 5.
[7]
Hanada S, Takewa Y, Mizuno T, Tsukiyan T, Taenaka Y, Tatsumi E, et al. Effect of the technique for assisting renal blood circula-tion on ischemic kidney in acute cardiorenal syndrome. J ArtifOrgans. 2012; 15: 140-5.
[8]
Lobo Márquez LL, de la Serna F. Síndrome cardiorrenal. Rev Fed Arg Cardiol. 2013; 42: 88-95.
[9]
Flores Blanco JP. Papel Pronóstico de Nuevos Métodos de Valoración de la Función Renal en Insuficiencia Cardiaca Aguda y Síndrome Coronario Agudo sin elevación del Segmento ST [Tesis Doctoral]. España: Universidad de Murcia; 2016.
[10]
Mora SD, Dávila EZ, Silva EN, Mesquita ET, Martins WdA, Villacorta Junior H. Síndrome cardio-renal tipo 1: Mecanismos fisiopatológicos y papel de los nuevos biomarcadores. Insuficiencia cardíaca. 2016; 11 (1): 55-62.
[11]
Tan K, Sethi S. Biomarkers in cardiorenal syndromes. TranslRes 2014; 164 (2): 122-34.
[12]
Seller Pérez G, Herrera Gutiérrez ME, Arias Verdú MD, De la Torre Prados MV, Cota Delgado. Fisiopatología de la insuficiencia renal aguda. Lesión renal en el paciente crítico. En: Cárdenas Cruz A, Roca Guiseris J, editores. Tratado de Medicina Intensiva. Barcelona: Elsevier; 2017. p. 395-9.
[13]
Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295.
[14]
Jose P, Skali H, Anavekar N, Tomson C, Krumholz HM, Rouleau JL, et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol 2006; 17: 2886-2891.
[15]
Landry DW, Bazari H. Aproximación al paciente con enfermedad renal. En: Goldman-Cecil. Tratado de medicina interna + Expert Consult. 25a Edición. Elsevier: España, 2017; 114: 728-36.
[16]
Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ van de Werf F, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. GRACE Investigators. JAMA. 2004; 291: 2727-33.
[17]
Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 2005; 45 (9): 1397-405.
[18]
Sánchez A, Pou M, Leiro R, López Gómez D, Martínez Ruiz M. D, Saurina A, et al. El grado de insuficiencia renal como predictor de mortalidad tras un síndrome coronario agudo. Nefrología 2009; 29 (1): 53-60.
Browse journals by subject